Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
5.72
-0.32 (-5.30%)
Feb 21, 2025, 4:00 PM EST - Market closed
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $256.19 million as of February 21, 2025. Its market cap has decreased by -56.78% in one year.
Market Cap
256.19M
Enterprise Value
189.15M
1-Year Change
-56.78%
Ranking
Category
Stock Price
$5.72
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $256.19M, a decrease of -67.84%. That is a compound annual growth rate of -16.19%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |